{ "id": "ded66f22-7d96-4e37-af66-c18fbf7048c6", "results": [ { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "- As of July 6, 2026, the amount of acute respiratory illness causing people to seek health care is very low.\n- RSV activity is low in most areas of the country.\nEmergency department visits and hospitalizations for RSV are low but remain highest among infants and children younger than 4 years old.\n- COVID-19 activity is low in most areas of t

Review of CDC provisional death data for 2025, detailing shifts in mortality rates and leading causes of death.

Summary of recent FDA regulatory actions for oncology and hematology drugs, including new approvals and fast-track designations.

Comprehensive report on U.S. healthcare expenditure trends for 2024, highlighting a 7.2% annual growth rate and sustained cost pressures.

{ "id": "e762a42b-9a3d-4b84-a8a6-166b2ab45aa7", "results": [ { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "- As of July 6, 2026, the amount of acute respiratory illness causing people to seek health care is very low.\n- RSV activity is low in most areas of the country.\nEmergency department visits and hospitalizations for RSV are low but remain highest among infants and children younger than 4 years old.\n- COVID-19 activity is low in most areas of t

Analysis of hospital payment policies, inpatient utilization, and the impact of federal reimbursement rules.

Early release of mortality data and death rates for the United States, providing a snapshot of public health trends.

Summary of recent FDA novel drug approvals and therapeutic decisions focusing on oncology and nephrology.

Updated figures on private and public insurance enrollment trends observed through late July 2026.

Analysis of national hospital bed occupancy rates and ED wait times over the final week of July 2026.

{ "id": "54ff2864-d115-4e0b-b8af-07f8380bb443", "results": [ { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "- As of July 6, 2026, the amount of acute respiratory illness causing people to seek health care is very low.\n- RSV activity is low in most areas of the country.\nEmergency department visits and hospitalizations for RSV are low but remain highest among infants and children younger than 4 years old.\n- COVID-19 activity is low in most areas of t

Congressional Budget Office (CBO) analysis regarding the long-term federal financial burden of health coverage subsidies.

Analysis of inpatient hospital capacity and utilization rates for Medicare-certified facilities.

Summary of recent regulatory milestones, including key oncology treatments and new therapy approvals.

Comprehensive report on U.S. healthcare expenditure trends, highlighting the second consecutive year of growth exceeding 7%.

{ "id": "c63e96e1-3663-45ef-bafb-89132c9b0663", "results": [ { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "- As of July 6, 2026, the amount of acute respiratory illness causing people to seek health care is very low.\n- RSV activity is low in most areas of the country.\nEmergency department visits and hospitalizations for RSV are low but remain highest among infants and children younger than 4 years old.\n- COVID-19 activity is low in most areas of t

Recent CDC data regarding provisional mortality rates and infectious disease outbreaks through July 2026.

Summary of recent FDA regulatory actions, including new oncology treatments and the advancement of specific therapies.

Comprehensive report on U.S. health expenditure trends, detailing a 7.2% growth rate that continues to outpace overall economic GDP growth.

The CMS Office of the Actuary released projections indicating that national health expenditure growth is expected to average 5.5% annually over 2017-2026.

The French government unveiled a budget plan for 2026 that includes €5 billion in healthcare spending cuts as part of a broader goal to save €43.8 billion.

In 2025, the United States' health care spending surged to $5.7 trillion, marking a 7.3% increase from the previous year, driven by increased demand for medical services and high-cost drugs.

The Centers for Medicare & Medicaid Services (CMS) finalized a 2.6% increase in Medicare inpatient hospital payments for fiscal year 2026, aiming to support hospitals treating a high number of low-income patients.

HCA Healthcare announced its financial and operating results for the second quarter ended June 30, 2026, showing significant growth in revenues and admissions.